Background::Total ankle replacement (TAR) is a viable option for the treatment of end-stage ankle arthritis. In China, the INBONE-II implant is the only total ankle prosthesis approved since 2016. The purpose of this study is to report a large sample of findings for the TAR with INBONE-II prosthesis.Methods::A total of 64 patients with end-stage ankle arthritis, who underwent primary TAR using INBONE-II by the same surgeon from 2016 to 2019, at a single institution were included in this retrospective, single-center study. Clinical data, radiographic findings, survival rate, and complications were recorded and assessed pre-operatively and at the most recent follow-up.Results::A total of 64 patients were available for follow-up at least 2 years after surgery; the mean follow-up duration for clinical outcomes was 37.9 months (24–59 months), and for radiographic findings was 22.8 months (12–59 months). There were significant improvements ( P < 0.01) in the American Orthopedic Foot and Ankle Society hindfoot scale, the visual analog scale for pain, and the Short Form-36. There were statistically significant differences between pre-operative and post-operative comparisons of the talar tilt angle (TT) and the tibial lateral surface angle (TLS) in the radiographic findings (TT from 4.7 ± 4.3° to 1.3 ± 1.3°, TLS from 80.4 ± 7.7° to 87.4 ± 2.3°, P < 0.01). There was no statistically significant difference in improvement of the tibial anterior surface angle ( P = 0.14). Ten complications (all low grade) were recorded according to the Glazebrook classification system. The survivorship of the prosthesis was 100% (64/64). Conclusion::Patients who underwent TAR with INBONE-II prosthesis demonstrated significant improvements in all measures of pain and function as well as in radiographic findings. High survival and a low incidence of complications were observed in this study.

Total ankle replacement;Total ankle arthroplasty;Outcomes;Complications;INBONE-II

Wu Yong;Yang Hanyuan;Guo Xiangbin;Du Hui;Gong Xiaofeng

Department of Foot and Ankle Surgery, Beijing Jishuitan Hospital, Beijing 100035, China;Department of Foot and Ankle Surgery, Beijing Chaoyang Emergency Medical Center, Beijing 100021, China

中华医学杂志（英文版）

[1]Wu Yong;Yang Hanyuan;Guo Xiangbin;Du Hui;Gong Xiaofeng-.Total ankle replacement with INBONE-II prosthesis: A short-to-medium-term follow-up study in China)[J].中华医学杂志（英文版）,2022(12):1459-1465

INBONE,Glazebrook,survivorship

Total,ankle,replacement,II,prosthesis,short,medium,term,follow,up,study,China,Background,TAR,viable,option,treatment,end,stage,arthritis,In,implant,only,total,approved,since,purpose,this,report,large,sample,findings,Methods,patients,who,underwent,primary,using,by,same,surgeon,from,single,institution,were,included,retrospective,center,Clinical,data,radiographic,survival,complications,recorded,assessed,pre,operatively,most,recent,Results,available,least,years,after,surgery,mean,duration,clinical,outcomes,was,months,There,significant,improvements,American,Orthopedic,Foot,Ankle,Society,hindfoot,scale,visual,analog,pain,Short,Form,statistically,differences,between,post,comparisons,talar,tilt,angle,TT,tibial,lateral,surface,TLS,no,anterior,Ten,grade,according,classification,system,Conclusion,Patients,demonstrated,measures,function,well,High,incidence,observed,arthroplasty,Outcomes,Complications

0.453098